PDE-5 inhibitors

Alona Crowder, PharmD, Ari S. Eckman, M.D.



  • Treatment of erectile dysfunction (ED)
  • Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening (Revatio and Adcirca)
  • Treatment of benign prostatic hyperplasia (Cialis)

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: January 7, 2018